Hy. Ho et al., OVEREXPRESSION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE KINASE REVERSED CAMP INHIBITION OF NF-KAPPA-B IN T-CELLS, European Journal of Immunology, 27(1), 1997, pp. 222-226
cAMP inhibits T cell activation by acting as an antagonist for selecti
ve kinases and transcriptional factors. We have recently demonstrated
that cAMP inhibited c-Jun N-terminal kinase (JNK) but left the mitogen
-activated protein (MAP) kinase cascade almost unaffected in T lymphoc
ytes. In accordance with recent reports, we also observed a selective
suppression of nuclear factor NF-kappa B activation by cAMP. The possi
ble link between the JNK cascade and NF-kappa B activation was demonst
rated by the fact that the active form of MAP kinase kinase kinase (De
lta MEKK), a constitutive activator of JNK, induced NF-kappa B but not
AP-1, Oct, and NF-AT in T cells. In contrast, the induction of MAP ki
nase kinase (MEK)-MAP kinase did not stimulate NF-kappa B activity. Th
e specific activation of NF-kappa B by a single MEKK-JNK cascade was t
hus unusual, given that the activation of other transcriptional elemen
ts in T cells requires at least two signal pathways. This was further
confirmed by the fact that cAMP inhibition of NF-kappa B activation wa
s reversed by overexpression of Delta MEKK.